Standard Biotools (LAB) Net Cash Flow Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 269.22% |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn | -48.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.34% |
| Mar 31, 2026 | 65.08% |
| Dec 31, 2025 | -34.15% |
| Sep 30, 2025 | -27.83% |
| Jun 30, 2025 | -46.25% |
| Mar 31, 2025 | -127.10% |
| Sep 30, 2024 | -14.44% |
| Jun 30, 2024 | 23.16% |
| Mar 31, 2024 | 143.92% |
| Dec 31, 2023 | -89.78% |
| Sep 30, 2023 | -60.74% |
| Jun 30, 2023 | 54.10% |
| Mar 31, 2023 | 36.37% |
| Dec 31, 2022 | 89.93% |
| Sep 30, 2022 | -112.73% |
| Jun 30, 2022 | 46.31% |
| Mar 31, 2022 | 27.12% |
| Sep 30, 2021 | -125.86% |
| Jun 30, 2021 | -157.38% |
| Mar 31, 2021 | -4.54% |